arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

PFIZER INC

PFE
$26.02 ▲ +0.23 (+0.89%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
74 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

PFIZER INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $148.1B
Dividend Yield
Revenue Growth 5.4%
Op. Margin
ROIC
FCF / Share $0.38
Trailing P/E 55.4x
Price / Book 1.6x
FCF Yield 1.5%
Debt / Equity 0.67
info Valuation on last close. End-of-day price, Aug 6, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$14.45B
↑ +5.4%
Net Income Profit after all expenses
$2.69B
↓ -9.4%
FCF / Share Free cash flow per share
$0.38
↑ +22.7%
Long-Term Debt Long-term obligations
$60.56B
↓ -1.7%

Health Breakdown

Profitability
70
Returns
64
Financial Health
39
Cash Quality
72

Dividend History

Dividend / share · sourced from SEC filings
$1.72 Latest / share
+1.8% YoY
+4.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters